
A third of vaping teenagers likely to take up smoking cigarettes, study finds
A long-term study found that teenagers who vape now are 33 per cent more likely to take up tobacco compared to those who don't, despite decades of falling smoking rates.
The study, published in the journal Tobacco Control, showed a decline in teenage smoking prevalence, falling from 33 per cent in 1974 to 25 per cent in 1986, and to 12 per cent in 2018.
This is due to tougher tobacco control laws and a greater awareness of smoking's dangers, the researchers said.
However, the research also revealed that among today's teens, those who vape remain just as likely to smoke cigarettes as their peers half a century ago.
The study, led by the University of Michigan, found that only around 1.5 per cent of non- vaping 17-year-olds reported current smoking, compared with 33 per cent of those who currently vaped.
'This probability is especially concerning given the recent increases in e-cigarette use prevalence among UK youth, despite some initial assurances that e-cigarettes would have little appeal to [them],' the researchers said.
In the UK, an estimated 1.1 million young people between the ages of 11 and 17 vape and 100,000 smoke, according to figures from Action on Smoking and Health (Ash).
The researchers analysed intergenerational data from three major British cohort studies – the 1958 National Child Development Study, the 1970 British Cohort Study, and the 2001 Millennium Cohort Study.
The researchers looked at several risk factors that can influence teen smoking. This includes early alcohol use, parental smoking, mothers' education, and children's engagement with school.
They found that some of these factors have changed over time, such as parental smoking rates, which have dropped from more than 70 per cent in the 1970s cohort to 27 per cent among the most recent group.
Despite these changes, vaping appears to undermine progress, the researchers said. They found that among current teen vapers, the likelihood of also smoking cigarettes has effectively reversed the declining trend.
'Youth who had never used e-cigarettes had an estimated less than one in 50 chance of reporting weekly cigarette use at age 17, while those who had previously used e-cigarettes had over a one in 10 chance,' the researchers said.
'Youth who reported current e-cigarette use had an almost one in three chance of also reporting current cigarette use.'
The study's authors cautioned that the findings do not prove vaping directly causes smoking. However, they warned that efforts to reduce smoking among young people must now also address vaping.
'Among contemporary youth, efforts to reduce cigarette smoking should focus both on those who are currently using e-cigarettes and on the prevention of e-cigarette use among youth, to maintain the promising declines in youth nicotine use in years to come,' they concluded.
A ban on disposable vapes came into force in the UK at the beginning of June as the government attempts to crack down on youth nicotine addiction as well as the litter the single-use devices create.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
5 minutes ago
- The Independent
July was Earth's third-warmest on record, EU scientists say
The world experienced it's third-warmest July on record this year, the European Union agency that tracks global warming said Thursday, after two consecutive years when temperatures soared past previous records. Despite a slightly lower global average temperature, the scientists said extremes — including heat and deadly floods — persisted in July. 'Two years after the hottest July on record, the recent streak of global temperature records is over — for now. But this doesn't mean climate change has stopped,' said Carlo Buontempo, director of the Copernicus Climate Change Service. 'We continued to witness the effects of a warming world.' The EU monitoring agency said new temperature records and more climate extremes are to be expected unless greenhouse gas concentrations in the atmosphere are brought down. On July 25, Turkey recorded it's highest-ever temperature of 50.5 C (122.9 F) as it battled wildfires. While not as hot as July 2023 or July 2024, the hottest and second-warmest on record, the Copernicus Climate Change Service reported that the planet's average surface temperature last month was still 1.25 C (2.25 F) above the 1850-1900 pre-industrial period, before humans began the widespread burning of oil, gas and coal. It said the average global surface air temperature reached 16.68 C (62.02 F) in July, which is 0.45 C (0.81 F) above the 1991-2020 average for the month. Greenhouse gases released from the burning of fossil fuels like gasoline, oil and coal are the main cause of climate change. Despite a somewhat cooler July, the 12-month period between August 2024 and July 2025 was 1.53 C above pre-industrial levels, exceeding the threshold set in 2015 to limit human-caused warming to 1.5 C (2.7 F). Copernicus is the European Union's earth observation system based on satellite and on-the-ground data collection. Britain rejoined the climate agency in 2023. Julien Nicolas, a senior Copernicus scientist, said it was important to view last month's decrease in the context of two anomalous years in terms of warming. 'We are really coming out from a streak of global temperature records that lasted almost two years,' Nicolas said. 'It was a very exceptional streak." He added that as long as the long-term warming trend persists, extreme weather events will continue to happen.


The Sun
6 minutes ago
- The Sun
Popular spread is pulled from UK supermarket shelves over metal SHARDS as shoppers warned ‘do not eat'
A POPULAR spread has been pulled from supermarket shelves after metal shards were found in jars. The Food Standards Agency has issued a warning that Daylesford Organic's Cacao Double Nut Butter poses a safety risk because of possible metal ball bearing contamination. The agency has confirmed that the company, which is based in Chipping Norton, Oxfordshire, has removed certain batches of the item from retail outlets. The Food Standards Agency is telling shoppers: "If you have bought the above product do not eat it. "Instead, return it to the store from where it was bought for a full refund." An online description of the product, which comes in 230g containers, reads: "Made in small batches from the highest quality roasted cashews and hazelnuts, ground with cacao. "Perfect for sandwiches, smoothies, puddings and baking."


Reuters
6 minutes ago
- Reuters
Danish drugmakers jump as Eli Lilly's weight-loss pill data disappoints
Aug 7 (Reuters) - Shares in Novo Nordisk ( opens new tab rose as much as 14% on Thursday after trial data from Eli Lilly's (LLY.N), opens new tab experimental weight-loss pill fell short of expectations, boosting investor confidence in the Danish drugmaker's market-leading obesity treatment. The company later pared some gains and were trading up 9% at 1240GMT. The market had anticipated Eli Lilly's orforglipron pill to become a strong competitor to Novo's weight-loss drugs, Kepler Cheuvreux analyst David Evans said in an emailed comment. However, with Thursday's results falling short of those expectations, Evans said investors were likely to rethink the competitive outlook in the GLP-1 obesity drug market, a shift that favours Novo's oral semaglutide. Eli Lilly shares were down 7.8% premarket at 1152 GMT. The battle between injectables and oral GLP-1 drugs is shaping obesity treatments, as companies race to deliver the best mix of results and safety for patients. Novo's shares plunged last week after it slashed its outlook for 2025 sales growth, marking the second forecast cut for the Danish drugmaker this year. Lilly's weaker pill data helps restore investor confidence in Novo's obesity lead, easing fears of an imminent threat to Wegovy's dominance and pricing power, Nordnet analyst Per Hansen has said. Novo's domestic peer Zealand Pharma ( opens new tab rose around 7% in afternoon trade. Shares in Germany's Gerresheimer ( opens new tab, maker of injector pens for Wegovy and Zepbound, also rose around 3%, as weaker oral pill data points to sustained demand for injectable obesity treatments. Up to the previous session's close, Novo and Zealand shares had lost more than half their value since the start of the year.